Publicacions en què col·labora amb ALBERTO SOLA LEYVA (4)

2024

  1. Directing novel ChoKα1 inhibitors using MamC-mediated biomimetic magnetic nanoparticles: a way to improve specificity and efficiency

    Bioorganic Chemistry, Vol. 151

2022

  1. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

    Pharmaceutics, Vol. 14, Núm. 2

2019

  1. Biomimetic magnetic nanocarriers drive choline kinase alpha inhibitor inside cancer cells for combined chemo-hyperthermia therapy

    Pharmaceutics, Vol. 11, Núm. 8

  2. Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells

    Scientific Reports, Vol. 9, Núm. 1